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Background/aim: The role of nitric oxide (NO) has been established in infection over the years. NO functions by inhibiting the growth
of intracellular pathogens. The present study was undertaken to ascertain the role of NO in central nervous system (CNS) infection by
Mycobacterium tuberculosis.
Materials and methods: A total of 781 chronic meningitis cerebrospinal fluid (CSF) samples suspected of CNS tuberculosis (TB) were
categorized based on M. tuberculosis culture positivity, anti-TB antibody response, and CSF cell count and were analyzed for NO.
Results: We found that NO levels were positive in 10.88% of the CSF samples. Positivity for NO was 18%, 11.67%, 13.68%, 9.32%, and
9.66% in the cases with mycobacterial culture positivity, anti-TB antibody positivity, high cell count, low cell count, and zero cell count,
respectively. Among the above cell count categories, NO levels were noticed to be elevated in high cell count samples with mononuclear
cell predominance.
Conclusion: This study suggests that NO might play some role in the later stages of tuberculous meningitis. This is the first study to our
knowledge in which NO was evaluated in CSF in relation to immune response and the presence of a pathogen with such a large number
of subjects.
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1. Introduction
Pathogenesis of infections involves the host’s innate defense
against infection by host immune cells. Variations in
immune response against various invading pathogens are
seen in experimental animals and also in in vitro studies
(1). In central nervous system (CNS) infections, brain cells
such as astrocytes, microglial cells, and endothelial cells
help in removal of pathogens by producing inflammatory
cytokines and different gaseous molecules such as nitric
oxide (NO) (2). NO is found to have diverse functions in
the pathophysiology of diseases and is involved in many
microbial infections. NO functions by inhibiting the
growth of intracellular pathogens (3). It is produced as
a gaseous molecule by the enzyme nitric oxide synthase
(NOS) from L-arginine. There are three isoforms of
NOS; one is of endothelial origin (eNOS) expressed
constitutively in endothelium, one is of neuronal origin
(nNOS) expressed in neurons, and the third is the
inducible form (iNOS) expressed in macrophages and
microglial cells (macrophages of the brain) (4). iNOS
expression is induced by cytokines released in response
* Correspondence: shripadpatil@yahoo.com

to infections from macrophages (4). NO produced by
iNOS has antibacterial activity, which causes breaks in the
nucleic acid along with other physiological activities such
as vasodilation and wound repair (2).
Knockout studies of murine models for the iNOS
gene have shown its association with different infections
such as tuberculosis, malaria, and leishmaniasis (5). NO
acts indirectly through its reactive nitrogen intermediates
formed after oxidation, such as peroxynitrite and
nitrosothiols, which are responsible for damage to the
CNS during meningitis (5). NO is very unstable and it gets
converted to the NO end products, nitrite and nitrate, a
few seconds after its release. Concentrations of NO end
products are seen to be increased in meningitis (5).
The role of NO in tuberculous meningitis (TBM) is still
not clearly understood. Macrophages play a major role in
the host response against Mycobacterium tuberculosis
(Mtb), the causative agent of TBM. Cytokines produced
by macrophages and T-lymphocytes in response to Mtb
infection activate macrophages to induce iNOS for the
production of NO, which in turn acts along with other
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reactive nitrogen intermediates to inhibit/kill Mtb in
murine models (2). However, in humans, the evidence is
less clear; although iNOS expression is seen in astrocytes it
is difficult to demonstrate in microglia (6).
The present study was undertaken to ascertain the role
of NO in the cerebrospinal fluid (CSF) of TBM patients.
The diagnosis of TBM is generally based on clinical
features such as fever, headache, and altered sensorium
and CSF findings such as pleocytosis, high protein, and
low CSF/blood glucose and presence of basal exudates
seen in imaging. Microbiological diagnosis is made by
observing acid-fast bacilli (AFB) in the CSF by Ziehl–
Neelsen staining, by culturing of CSF on suitable media
such as Lowenstein–Jensen (LJ) or Middlebrook media,
or immunologically by detection of antigens or antibodies
specific for Mtb in the CSF or by using nucleic acid
amplification methods (7). All the detection methods for
Mtb have their own limitations with different sensitivity
and specificity (8). The aim of the present study was to
correlate the presence of NO in the disease process of CNS
tuberculosis to a detailed extent using 781 CSF samples
of various categories. The parameters considered for the
present study in relation to NO were antibody response
for Mtb, CSF culture positivity for AFB, and CSF cell count
and cell type.
2. Materials and methods
2.1. Samples
Patients’ CSF samples received in the Department of
Neuromicrobiology, National Institute of Mental Health
and Neurosciences (NIMHANS), Bangalore, India,
were used for the study. The study group included
prospectively collected chronic meningitis CSF samples
of 781 consecutive patients of all age groups from June
2012 to June 2013. Ethical approval for the present study
was obtained from the institutional ethics committee.
Informed consent was obtained for lumbar puncture CSF
samples from human subjects. Clinical diagnosis was
made as per the disease guidelines. Patients were suspected
of TBM based on clinical presentations such as fever and
headache for more than 14 days, vomiting, neck stiffness,
altered sensorium, and focal neurological deficits, along
with preliminary laboratory evidence like decreased
glucose and increased protein levels in the CSF samples.
Closely mimicking diseases like neurocysticercosis and
cryptococcal meningitis were ruled out. All the samples
were processed for cell count, cell type, isolation of Mtb,
presence of anti-Mtb antibody, and NO assay.
2.2. Cell count and cell type
The CSF was analyzed for cell count by using a Neubauer
hemocytometer chamber using bright-field microscopy
with a 40× objective as a routine diagnostic procedure
in the lab. Samples with a total cell count of >20 cells/
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mm3 were considered as having a high cell count and
≤20 cells/mm3 as low cell count, and samples were also
categorized as having predominantly polymorphonuclear
or mononuclear cells or nil cells.
2.3. Isolation of Mtb by culture
CSF was cultured for Mtb by the conventional method on
LJ medium and/or the automated mycobacterial growth
indicator tube (MGIT) method. According to the standard
protocol for the conventional method, 200–500 µL of CSF
was inoculated aseptically on LJ medium, incubated at 37
°C, and observed weekly for 8 weeks. CSF was also cultured
in the BACTEC MGIT 960 system for rapid growth of the
bacteria as per the manufacturer’s instructions (9). In all
positive culture tubes, to confirm the presence or absence
of mycobacteria, Ziehl–Neelsen staining was done.
2.4. Indirect ELISA for anti-Mtb antibody
The methodology used for ELISA was described earlier
(10). Briefly, microtiter plates (TPP, Trassadingen,
Switzerland) were coated with 50 µL (10 µg/mL) of
mycobacterial (H37Rv) total sonicated antigen dissolved
in phosphate-buffered saline by overnight incubation at 4
°C in a moist chamber. Unbound antigen was removed by
washing with PBS-Tween 20 (PBST, 0.05%). Nonspecific
free binding sites were blocked with freshly prepared
PBST-milk (1%, w/v) at 37 °C for 2 h. The CSF samples to
be tested were diluted (1:5) in PBST milk (1%, w/v) and
the diluted samples were added to the plate in duplicates of
50 µL along with positive and negative controls. The plate
was incubated for 90 min in a moist chamber at 37 °C and
then washed 5 times with PBST. Secondary antibody (IgG)
conjugated with horse radish peroxidase (1:3000 dilutions
in PBST-milk; Dakopatts, Denmark) was added to each
well (50 µL) and incubated in a moist chamber at 37 °C
for 60 min. Substrate (O-phenylene di-amine; Sigma, St.
Louis, MO, USA) dissolved in phosphate citrate buffer (0.1
M, pH 5) containing 0.01% hydrogen peroxide was added
to each well (75 µL) and color development was allowed
for 10–15 min. The reaction was arrested by adding 50 µL
of 2 N sulfuric acid. The readings were taken by ELISA
reader (Sunrise-Magellan, Tecan AG, Austria) at 492 nm.
The positive cut-off value considered was ≥0.100 OD,
calculated on the basis of the absorbance value (OD)
of healthy controls by taking the mean of it plus three
standard deviations (SDs).
2.5. Nitric oxide assay
NO is detected using a colorimetric assay based on a
chemical diazotization reaction originally described by
Griess in 1879 (11). NO was analyzed by the reaction
of its end oxidation product (nitrite) for the formation
of a purplish pink color with the Griess reagent. In this
reagent, sulfanilic acid forms a diazonium salt with nitrite
in the CSF sample, which then reacts with the azo dye
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agent (N-alpha-naphthyl-ethylenediamine) to form a
chromophore. This is detected colorimetrically at 540 nm
(12).
The standard reference curve was prepared with each
set of samples analyzed with 1:1 serial dilutions of sodium
nitrite (10 mM) in distilled water. The first 2 columns in
the 96-well plate were for the standards (50 µL/well). CSF
samples (50 µL) were added to the remaining wells. Solution
A containing 1% sulfanilamide in 5% phosphoric acid was
mixed with an equal volume of Solution B containing
0.1% N-1-naphthylethylenediamine dihydrochloride
in water prior to use. The prepared reagent (50 µL) was
added to the plate containing the CSF sample. The final
volume in each well was 100 µL. The reaction was allowed
to proceed for 10 min, which forms a purplish pink color.
Absorbance was measured at 540 nm in the ELISA plate
reader (Sunrise-Magellan, Tecan AG).
2.6. Statistical analysis
Statistical analysis was done using GraphPad online free
statistical software. Pearson’s chi-square test was used to
compare discrete variables (NO, anti-Mtb antibody, and
Mtb culture report). Relations between mononuclear cells,
polymorphocytes, and NO were analyzed by chi-square
test. Categorical data were expressed as means with 95%
confidence intervals. P ≤ 0.05 was considered statistically
significant.
3. Results
Among 781 CSF samples, 484 were from males with an
age of 36.10 ± 16.66 years (mean ± SD) and 297 were from
females of 35.06 ± 17.57 years of age. The NO standard
curve was plotted with nitrite concentration on the x-axis
and absorbance on the y-axis for the known concentrations
of sodium nitrite. The concentration of NO in the CSF

samples was determined using the linear regression curve.
The correlation coefficient (R2) of the values with that of
the trend line obtained for the standard curve was 0.9974.
The samples containing NO above 9.7 µM were considered
positive for the assay based on the test samples and ruling
out background values.
Out of 781 samples, 50 Mtb cultures were isolated by
conventional or automated method. Out of 50 samples
analyzed, 31 (62%) were positive for the anti-Mtb antibody
and 9 (18%) were positive for NO. Among those, 5 (10%)
samples were positive for both the anti-Mtb antibody and
NO (Table 1). Among the culture-positive samples, 6 had
polymorphs as the predominant cell type but none of
them were positive for NO. Among 731 culture-negative
samples, 167 (22.84%) samples were positive for anti-Mtb
antibody and 76 (10.39%) were positive for NO. Among
those, 18 (2.46%) samples were positive for both anti-Mtb
antibody and NO.
The mean NO level obtained for all culture-positive
samples (n = 50) was 1.5 µM, and the values ranged from
0 to 19 µM. Among the culture-positive samples, the
mean value of NO in anti-Mtb antibody- and NO-positive
samples was 11.2 µM. For anti-Mtb antibody-negative
but nitrite-positive samples it was 9.8 µM. For anti-Mtb
antibody- and nitrite-negative samples the value was
around 2.9 µM. For anti-Mtb antibody-positive but nitritenegative samples it was 0.34 µM. However, statistically,
there was no significant correlation (P = 0.095) found
between culture positivity and NO by the Pearson chisquare test.
The CSF samples were also grouped based on their cell
count as having low and high cell counts as well as having
mononuclear cells predominant or polymorphonuclear
cells predominant, along with nil cells also considered
as one of the categories. In 781 CSF samples analyzed,

Table 1. NO assay results among different categories of suspected tuberculous meningitis cases. The samples with NO
above 9.7 µM were considered positive for the assay. Values in parentheses show percentages in comparison with the
culture report.
Mtb culture

Positive
n = 50

Cell count
High n = 45
Low n = 5
High n = 218

Negative
n = 731

Low n = 306
Nil n = 207

Predominant
cell type

Anti-Mtb
antibody positive

NO assay
positive

Mononuclear cells, n = 40

25 (50)

5 (10)

Polymorphonuclear cells, n = 5

3 (6)

0

Mononuclear cells, n = 4

3 (6)

0

Polymorphonuclear cells, n = 1

0

0

Mononuclear cells, n = 183

80 (10.94)

11 (1.5)

Polymorphonuclear cells, n = 35

22 (3)

2 (0.27)

Mononuclear cells, n = 286

49 (6.7)

5 (0.68)

Polymorphonuclear cells, n = 20

3 (0.41)

0

13 (1.77)

0
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311 samples had low cell counts, 263 samples had high
cell counts, and 207 samples had nil cells (Table 1). NO
positivity was higher among the samples with high cell
count, followed by low cell count and then nil cell samples.
However, statistically, no significant correlation (P =
0.355) was found between cell count and NO. Statistical
values of P = 0.106 and P = 0.092 were obtained between
mononuclear and polymorphonuclear predominant cells
and NO, respectively, which were not statistically significant
by Pearson chi-square test.
The graphical representation in the Figure was calculated
by applying a 3-way Venn diagram for the CSF samples
positive for any of the three tests among the 781 samples.
The nonoverlapping region represents CSF samples positive
for one of the tests. The areas that intersect represent the
overlapping of two or three tests. Among them, 58 samples
were positive only for nitric oxide, 148 samples were positive
only for anti-Mtb antibody, and 15 samples were positive
only for Mtb culture, while 18 samples were positive for
both NO and anti-Mtb antibody (Figure). The remaining
506 samples were negative for all three of the tests.
Among the 781 CSF samples suspected of TBM, 198
(25.35%) samples were positive for the presence of anti-Mtb
antibodies (Table 2). Among these samples, 23 (11.62%)
were positive by NO assay. Out of 583 (74.65%) Mtb
antibody-negative samples, 62 (10.63%) were positive for
NO. However, no significant correlation was found (P =
0.702) between anti-Mtb antibody and NO assay by Pearson
chi-square test. Overall, 85 (10.88%) samples showed
positivity for the NO assay.
4. Discussion
Study of host response to pathogens like mycobacteria is
essential due to high mortality of up to 50% and varying

associated neurological sequelae among TBM survivors,
especially in high-burden countries like India (13). The
organism plays a vital role in modulating the host immune
response. NO is found to play a role in TBM in mouse
models, but there are few studies with human subjects. The
role of NO has been established in disease processes over
the years (14). It is shown that NO plays a role similar to
cytokines in the disease process.
In the CSF, NO in the presence of oxygen gets
converted to nitrite and then to nitrate, but the CSF nitrate
levels may also be influenced by the damaged blood–brain
barrier wherein the nitrate in the circulation can diffuse
into the CSF (15). In the case of TBM, alteration in the
blood–brain barrier permeability is known (16). CSF
nitrate levels during bacterial meningitis are more varied
than nitrite levels (17). Hence, CSF nitrite levels will be
more specific and indicative of central nervous system
NO production (18). Hence, in the present study we have
considered nitrite measurements.
NO acts as an internal mediator in the CNS and in the
case of excessive production it may be neurotoxic (19).
The regulation of iNOS expression for the production of
NO is a complex process, may depend on cell type and
differentiation stage, and could be stimulus-dependent,
making the extrapolation of animal studies to clinical
settings difficult (5). It is also reported that NO levels in
the CSF may vary depending on the levels of stimulatory
and inhibitory cytokines. It is also reported that avirulent
strains produce more NO in comparison to virulent strains
(4). Furthermore, murine studies have shown that iNOS-/specimens are good models of human TBM (20).
The metabolic pathways and the half-life of nitrite in the
CSF are still unknown (21). In a study on TBM, increased
levels of NO along with arginine were found to be of

Figure. Venn diagram representing the number of CSF samples positive for anti-Mtb
antibody, NO assay, and Mtb culture.
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Table 2. Comparison of anti-Mtb antibody and NO among suspected tuberculous meningitis
cases. Values in parentheses show percentages.
NO assay
Positive
Anti-Mtb antibody ELISA

Negative

Total

Positive

23

175

198 (25.35)

Negative

62

521

583 (74.65)

Total

85 (10.88)

696 (89.11)

781

significance in neuronal death (22). According to previous
studies, NO serves as a nonspecific immune modulator
and it has an influence on prognosis. It is seen in other
studies that the lack or reduction of NO production might
play a role in latent infection (23). It was also observed that
Mtb resistant to NO causes severe disease outcome (24).
The presence of AFB in the CSF, which is regarded as
the gold standard for diagnosis of TBM, has revealed the
presence of NO in about 18% of the cases. Even though
Mtb is known to generate nitrite, the NO production by
Mtb may be negligible as the bacterial load itself is very
low in the CSF. In the present study, about 82% of the
culture-positive samples were negative for the presence
of NO. This could probably be regarded as a stage in
which the immune response is not yet properly geared or
it is damaged. It is interesting to note that mycobacterial
culture positivity is also seen among a few CSF samples
with low cell counts, but none of them were NO-positive.
Due to low culture positivity in the CSF of TBM
cases, immunodiagnosis is regarded as an important
marker for the disease diagnosis. The present study has
revealed less difference between NO levels of both antiMtb antibody-positive and -negative cases. However,
the anti-Mtb antibody in CSF samples did not show a
significant correlation with NO. This is the first study
to our knowledge in which antibody response against
mycobacteria is correlated with NO.
It was reported that measuring NO in the CSF would
not reliably distinguish bacterial meningitis from other
causes of fever. It was also reported that there was no
relationship between CSF NO concentration and CSF
leukocyte count (25). Our study is in agreement with this
finding. CSF cells, which are regarded as disease/immune
markers in any CNS infection, presented a poor picture
for NO with 90% of the 781 samples analyzed showing

undetectable levels of NO. It is surprising to note that
high cell count has no direct relation with the presence
of NO. However, within the group marginally increased
levels of NO were seen in high cell count CSF samples with
mononuclear cell predominance and were least among
CSF samples with high cell counts and polymorphonuclear
cells predominant. This suggests that NO might play some
role in the very later stages of TBM, where the disease
sets in with high mononuclear cell response. However, in
the initial stage of the disease, where an increased level
of polymorphic cell response is seen, the role of NO is
unclear.
In this study we focused on NO levels and its presence
in the CSF of TBM cases. This is the first study to our
knowledge in which NO was evaluated in the CSF in
relation to antipathogenic antibody response, CSF cell
count and cell type, and the presence of pathogen by culture
with such a large number of subjects. It can be concluded
from the present study that there is a marginal increase
in NO among high CSF cell counts with mononuclear
cells, though not statistically significant. Thus, it appears
that NO does not directly influence the disease process.
However, it appears that NO in association with cytokines
might play an immunopathological role in the disease
process.
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